Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 7, 2015, Pages 1273-1277

  Mehta, Parinda A ^a   Zhang, Mei Jie ^b   Eapen, Mary ^b   He, Wensheng ^b   Seber, Adriana ^c   Gibson, Brenda ^d   Camitta, Bruce M ^b   Kitko, Carrie L ^e   Dvorak, Christopher C ^f   Nemecek, Eneida R ^g   Frangoul, Haydar A ^h   Abdel Azim, Hisham ⁱ   Kasow, Kimberly A ^j   Lehmann, Leslie ^k   Gonzalez Vicent, Marta ^l   Diaz Pérez, Miguel A ^l   Ayas, Mouhab ^m   Qayed, Muna ⁿ   Carpenter, Paul A ^o   Jodele, Sonata ^a   Lund, Troy C ^p   Leung, Wing H ^q   Davies, Stella M ^a   more..

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c HOSPITAL SAMARITANO   (Brazil)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k BOSTON CHILDREN S HOSPITAL   (United States)

^l HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^m KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o USA   (United States)

^p UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^q ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

more..

Author keywords

Hematopoietic stem cell transplantation; Hypodiploid acute lymphoblastic leukemia

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHILDHOOD MORTALITY; CHROMOSOME NUMBER; DIPLOIDY; DISEASE FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HYPODIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; ACUTE DISEASE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ANEUPLOIDY; GENETICS; GRAFT VS HOST DISEASE; IMMUNOLOGY; MORTALITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; RISK; SIBLING; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

IMMUNOSUPPRESSIVE AGENT; MYELOABLATIVE AGENT;

ACUTE DISEASE; ADOLESCENT; ANEUPLOIDY; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYELOABLATIVE AGONISTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK; SIBLINGS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84930582139     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.04.008     Document Type: Article

References (22)

1. Conter V., Arico M., Basso G., et al. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia 2010, 24:255-264.
2. Moricke A., Zimmermann M., Reiter A., et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2010, 24:265-284.
3. Hunger S.P., Lu X., Devidas M., et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. JClin Oncol 2012, 30:1663-1669.
4. Veerman A.J., Kamps W.A., van den Berg H., et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 2009, 10:957-966.
5. Schmiegelow K., Heyman M., Gustafsson G., et al. The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse. Leukemia 2010, 24:715-720.
6. Pui C.H., Campana D., Pei D., et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. NEngl J Med 2009, 360:2730-2741.
7. Mitchell C., Richards S., Harrison C.J., Eden T. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia 2010, 24:406-418.
8. Heerema N.A., Nachman J.B., Sather H.N., et al. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group. Blood 1999, 94:4036-4045.
9. Nachman J.B., Heerema N.A., Sather H., et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 2007, 110:1112-1115.
10. Harrison C.J., Moorman A.V., Broadfield Z.J., et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol 2004, 125:552-559.
11. Przepiorka D., Chan K.W., Champlin R.E., et al. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients. Bone Marrow Transplant 1995, 16:737-741.
12. Flowers M.E., Kansu E., Sullivan K.M. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999, 13:1091-1112.
13. Lin D.Y. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997, 16:901-910.
14. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc 1958, 53:457-481.
15. Cox D.R. Regression models and life-tables. JRoyal Statistical Soc Series B-Statistical Method 1972, 34:187-200.
16. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008, 14:748-758.
17. Schultz K.R., Pullen D.J., Sather H.N., et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 2007, 109:926-935.
18. Schultz K.R., Bowman W.P., Aledo A., et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. JClin Oncol 2009, 27:5175-5181.
19. Devidas M., Raetz E., Loh M., et al. Outcome for children with hypodiploid acute lymphoblastic leukemia (ALL) on Contemporary Children's Oncology Group (COG) Clinical Trials. Pediatr Blood Cancer 2013, 60:10a.
20. Schultz K.R., Devidas M., Bowman W.P., et al. Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031. Leukemia 2014, 28:964-967.
21. Holmfeldt L., Wei L., Diaz-Flores E., et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet 2013, 45:242-252.
22. Petitjean A., Mathe E., Kato S., et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007, 28:622-629.